Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MacroMed's OncoGel enters phase I

Oct. 27, 2000

Triazine derivative inhibits angiogenesis in vivo

Oct. 27, 2000

Leukemia treatment designated an orphan drug in Europe

Oct. 26, 2000

Guilford reacquires rights to Gliadel Wafer

Oct. 26, 2000

Intracel's phase III trial for bladder cancer approved by FDA

Oct. 26, 2000

Cancer therapy activates multiple apoptosis pathways

Oct. 25, 2000

Cyclic tetrapeptide antitumor agents designed at Japan Energy

Oct. 25, 2000

MGI Pharma selects pancreatic cancer as initial target in phase III trial of irofulven

Oct. 25, 2000

Bendamustine considered of little therapeutic value in heavily pretreated germ cell cancer

Oct. 25, 2000

Sanofi-Synthelabo recovers full rights to oxaliplatin for the U.S.

Oct. 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...